G2/M block abrogation drastically enhances the cytotoxicity of Daunorubicin, Melphalan and Cisplatin in TP53 mutant human tumour cells.
dc.contributor.author | Binder A | |
dc.contributor.author | Serafin A | |
dc.contributor.author | Bohm L | |
dc.date.accessioned | 2013-01-23T11:47:41Z | |
dc.date.available | 2013-01-23T11:47:41Z | |
dc.date.issued | 2001 | |
dc.description | Gesondheidswetenskappe | |
dc.description | Stralingsonkologie | |
dc.description | Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za | |
dc.identifier.citation | Radiation Research | |
dc.identifier.uri | http://hdl.handle.net/10019.1/74617 | |
dc.publisher | RADIATION RESEARCH SOC, 820 JORIE BOULEVARD, OAK BROOK, USA, IL, 60523 | |
dc.title | G2/M block abrogation drastically enhances the cytotoxicity of Daunorubicin, Melphalan and Cisplatin in TP53 mutant human tumour cells. | |
dc.type | Journal Articles (subsidised) |